home *** CD-ROM | disk | FTP | other *** search

---

/ Cancer - Principles & Practice of Oncology / Oncology.iso / PPO / CHAP53 / T8_3.GIF

< prev

next >

Graphics Interchange Format  |  1999-06-07  |  70KB  |  725x248  |  8-bit (240 colors)

Labels: book | box | bulletin board | dirt track | earth | fence | poster | shelf | sky | trade name | vegetarianism | window | windowpane
OCR: Testicular Cancer Years 0 Etoposide Therapy Observed Cases Relative Risk Study Cases Diagnosis Cumulative Dose Patients ofANLL/MDS O/F ratio) Cumulative Risk Pedersen-Bjergaard 1979-89 1800- -3600 mg/m ANLL MDS 336 4.7% at5.7 et al, 199194 2000 mg/m 130 2000 3600 mg/m 82 NA 11.3% at 5.7 Bajorin 166 et al. 340 1982 -90 1000 3500 mg/m NA 1% at5 1993 Bokemeyer and 293 1984 -90 2000 mg/m LALI NA 0.5% at5y Schmoil 1993 1 >2000 mg/m Nichols 538 1982 -9] 1500 2000 mg/m ANLI 66 1% at 5y 1993 Boshoff 105 et al, 679 1979- 99 500 2000 -5000 mg/m mg/m 636 ANLI NA 150 NA NA 199 >2000 mg/m 25 NA NA Etotoside Stuar ANLLIMDS Cunuatine Biergaard 00005 Bokemeve LALL Schmoll ANLJ

---